Navigation Links
Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review
Date:6/19/2013

Lexington, Mass. (PRWEB) June 19, 2013

Imprivata®, a leading global provider of healthcare IT security solutions, today announced that Imprivata OneSign® leads the single sign-on (SSO) category in the KLAS® 2013 Mid-Term Performance Review: Software & Services report. CIOs and other healthcare executives iwere nterviewed by KLAS laud Imprivata on the superior performance of its products and the quality of its customer service and support, and they indicate that Imprivata is integral to their long-term healthcare IT strategy.

“Imprivata is a strategic partner. The SSO product used in conjunction with smooth roaming creates an environment that is both efficient and highly valued by our users. Imprivata enables No Click Access™ to clinical systems and patient information that delivers both security and convenience that clinicians need to better focus on patient care,” said Bruce Hall, CIO of Augusta Health, a 255-bed hospital in Fisherville, Va. “In addition, Imprivata understands the evolving healthcare IT landscape. We expect Imprivata will remain central to our healthcare IT strategy over the long term.”

The KLAS 2013 Mid-Term Performance Review: Software & Services report profiles hundreds of software and services vendors, providing a detailed look at the performance of each company's product line. The report aggregates performance data gathered over the past 12 months. The findings represent the voice of thousands of providers sharing their candid experience with various healthcare technology and vendors. Imprivata OneSign received a score of 88.4, building on the company’s momentum from 2012 when it was recognized as the SSO category leader in the KLAS 2012 Top 20 Best in KLAS Awards report.

“KLAS rankings are derived directly from customer input, so our consistently high scores serve as strong independent validation of Imprivata’s products, customer service and strategic importance,” said Ed Gaudet, chief marketing officer of Imprivata. “Imprivata also has the highest U.S. market share among SSO providers, according to HIMSS Analytics data, which supports feedback that we regularly receive from customers—Imprivata is the most widely-used application in hospitals after the electronic medical records system. Imprivata is simplifying healthcare IT to enable our customers with better focus on patient care.”

About Imprivata
Imprivata, the leader in healthcare IT security, enables secure access and collaboration for two million healthcare users worldwide. As the #1 independent provider of single sign-on and access management solutions for healthcare and other regulated industries, Imprivata OneSign® Single Sign-On is exclusively endorsed by the American Hospital Association (AHA) and recognized by Gartner and KLAS. Imprivata Cortext™ is the leading free HIPAA compliant text messaging solution for healthcare. Headquartered in Lexington, Massachusetts, Imprivata serves 1,300 hospitals in partnership with over 200 EMR and technology infrastructure vendors around the world. For more information, please visit http://www.imprivata.com.

All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10848144.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. MEDITECH Customers According to HIMSS Analytics
2. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
3. Upstart Bachelorista Inc. Releases Tell-All Playbook For Single Women
4. Johns Hopkins surgeons among the first in the country to perform a robotic single-site hysterectomy
5. Talk Therapy Can Ease Depression, But No Single Type Deemed Best
6. LAPD Singles Out Narconon Drug Prevention and Education for Special Commendation
7. Northern Westchester Hospital Surgeon Reaches New Single-Incision Robot-Assisted Gallbladder Removal Surgery Milestone
8. Unique group for single fathers due to cancer offers support
9. Single Leg Deadlift Exercise Video Revealed By Bodyweight Torch
10. Single Concussion May Lead to Lasting Brain Damage
11. Single concussion may cause lasting brain damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on ... later, the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his ... the hospital’s 30th heart transplant recipient. , “He was playing at home, when we ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... AlignLife clinics nationwide ... Many children are not fortunate enough to receive bountiful gifts wrapped tightly under a ... can bring to the children of the world. , In exchange for generous donations, ...
(Date:12/7/2016)... OR (PRWEB) , ... December 07, 2016 , ... Sharon ... Water, Global Climate Change and Your Health on Voice of America, declared on her ... to call attention to the fact that when these bullies attack leaders in corporate ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers ... Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, ... with Delightful Deals on Botox® and Juvederm® just in time for the ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Research and Markets has announced the addition of the ... to 2021" report to their offering. ... , , The immunohistochemistry (IHC) ... a CAGR of 7.3% during the forecast period of 2016 to 2021. ... rapidly increasing geriatric population across the globe are the primary driving the ...
(Date:12/7/2016)... 7, 2016  Palatin Technologies, Inc. ("Palatin") (NYSE ... a previously disclosed underwritten public offering of units ... as sole book-running manager, Roth Capital Partners acted ... as co-manager for the offering. "This ... net proceeds, allowing us to continue advancing bremelanotide ...
(Date:12/7/2016)... , Dec. 7, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Janus Kinase 3 (JAK3) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
Breaking Medicine Technology: